Aberrant p53 alters DNA damage checkpoints in response to cisplatin: downregulation of CDK expression and activity

Katharine H Wrighton, Cecilia M Prêle, Andrew Sunters, W Andrew Yeudall

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Aberrant p53 alters DNA damage checkpoints in response to cisplatin: downregulation of CDK expression and activity'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology